Table 1.
Review of literature of ocular manifestations after COVID-19 vaccine.
| Study | Type | Rating Score * | Age (Years) | Sex | Vaccine | Dose | Duration between Vaccine and Ocular Symptoms (Days) | Diagnosis |
|---|---|---|---|---|---|---|---|---|
| Al Khames Aga et al. [10] | Retrospective cohort | 3 | N.A. | N.A. | BNT162B2 | N.A. | 1 | Eyelid swelling and allergy |
| Mazzatenta et al. [11] | Letter to editor | 5 | 44 63 67 |
F M F |
BNT162B2 BNT162B2 BNT162B2 |
2nd 2nd 1st |
21–25 21 10 |
Eyelid purpuric lesions Eyelid purpuric lesions Eyelid ecchymotic lesions |
| Furer et al. [12] | Case series | 4 | 56 | F | BNT162B2 | 1st | 4 | Herpes zoster ophthalmicus |
| Ravichandran et al. [13] | Case report | 5 | 62 | M | ChAdOx1 | 1st | 21 | Corneal graft rejection |
| Wasser et al. [14] | Case report | 5 | 73 56 |
M M |
BNT162B2 BNT162B2 |
1st 1st |
14 14 |
Corneal graft rejection Corneal graft rejection |
| Crnej et al. [15] | Letter to editor | 5 | 71 | M | BNT162B2 | 1st | 7 | Corneal graft rejection |
| Phylactou et al. [16] | Case report | 5 | 66 83 |
F F |
BNT162B2 BNT162B2 |
1st 2nd |
7 21 |
Corneal graft rejection Corneal graft rejection |
| Mambretti et al. [17] | Case report | 5 | 22 28 |
F F |
ChAdOx1 ChAdOx1 |
N.A. N.A. |
2 2 |
Acute macular neuroretinopathy Acute macular neuroretinopathy |
| Bøhler et al. [18] | Letter to editor | 5 | 27 | F | ChAdOx1 | 1st | 2 | Acute macular neuroretinopathy |
| Gabka et al. [19] | Case report | 5 | 20 | F | ChAdOx1 | N.A. | 1 | Acute macular neuroretinopathy |
| Book et al. [20] | Images | 5 | 21 | F | ChAdOx1 | 1st | 3 | Acute macular neuroretinopathy |
| Fowler et al. [21] | Case report | 5 | 33 | M | BNT162B2 | N.A. | 3 | Central serous retinopathy |
| Subramony et al. [22] | Case report | 5 | 22 | F | mRNA-1273 | 2nd | 15 | Retinal detachment |
| Renisi et al. [23] | Case report | 5 | 23 | M | BNT162B2 | 2nd | 14 | Acute anterior uveitis |
| Mudie et al. [24] | Case report | 5 | 43 | F | BNT162B2 | 2nd | 3 | Panuveitis |
| Goyal et al. [25] | Case report | 5 | 34 | M | ChAdOx1 | 2nd | 7 | Multifocal choroiditis |
| Maleki et al. [26] | Case report | 5 | 33 79 |
F F |
mRNA-1273 BNT162B2 |
2nd 2nd |
10 2 |
Acute zonal occult outer retinopathy Arteritic anterior ischemic optic neuropathy |
| Papasavvas et al. [27] | Case report | 5 | 43 | F | BNT162B2 | 2nd | 42 | Reactivation of Vogt-Koyanagi-Harada disease |
| Furer et al. [28] | Case-control study | 3 | N.A. | N.A. | BNT162B2 | 1st/2nd | N.A. | Uveitis |
| Helmchen et al. [29] | Letter to editor | 5 | 40 | F | ChAdOx1 | 1st | 14 | Optic/chiasm neuritis with longitudinal extensive transverse myelitis |
| Reyes-Capo et al. [30] | Case report | 5 | 59 | F | BNT162B2 | N.A. | 2 | Abducens nerve palsy |
| Panovska-Stavridis et al. [31] |
Letter to editor | 5 | 29 | F | ChAdOx1 | 1st | 9 | Superior ophthalmic vein thrombosis |
| Bayas et al. [32] | Images | 5 | 55 | F | ChAdOx1 | 1st | 10 | Superior ophthalmic vein thrombosis |
| Castelli et al. [33] | Letter to editor | 5 | 50 | M | ChAdOx1 | 1st | 11 | Cerebral venous sinus thrombosis |
| Wolf et al. [34] | Case series | 4 | 46 | F | ChAdOx1 | 1st | 13 | Cerebral venous sinus thrombosis |
| Suresh et al. [35] | Case report | 5 | 27 | M | ChAdOx1 | 1st | 2 | Cerebral venous sinus thrombosis |
| Dias et al. [36] | Case report | 5 | 47 | F | BNT162B2 | 1st | 6 | Cerebral venous sinus thrombosis |
| See et al. [37] | Case series | 4 | 18–39 | N.A. | Ad26.COV2.S | 1st | 6 | Cerebral venous sinus thrombosis |
| Blauenfeldt et al. [38] | Case report | 5 | 60 | F | ChAdOx1 | 1st | 8 | Acute ischemic stroke and bleeding |
| Santovito et al. [39] | Letter to editor | 5 | middle-aged | M | BNT162B2 | 2nd | 3 | N.A. |
| Kadali et al. [40] | Cross sectional study | 4 | N.A. | N.A. | BNT162B2 | N.A. | 1–42 | N.A. |